Blogs
Manuka Resources (ASX: MKR) Pulls Back as the Restart Rally Meets Its First Real Test
Manuka Resources is retracing after its May rally as investors await production milestones. With gold processing expected in July and silver production targeted for September, the market is looking for operational results to confirm the company's restart strategy.
Inoviq (ASX: IIQ)'s Breakout Reverses Hard: IIQ Slides After EXO-OC Study Reset
Inoviq shares plunged after sample-quality issues delayed validation of its EXO-OC ovarian cancer test, despite improved algorithm performance. The sharp reversal has shifted investor focus from growth potential to execution risks, timelines, and confidence in the company’s development strategy.
Macquarie Group (ASX: MQG): A High‑Conviction Financial Powerhouse
Macquarie Group (ASX: MQG) delivers muscular earnings growth, disciplined capital management and diversified global momentum, positioning itself as Australia’s premier financial powerhouse with sustainable mid‑teen returns and expanding shareholder value.
QBE Insurance Group (ASX: QBE): High-Conviction Income and Compounding Returns
QBE Insurance Group (ASX: QBE) delivers disciplined underwriting, robust investment returns and rising capital returns, offering high-conviction, income-led exposure to global commercial insurance with upside from sustained double-digit ROE and capital-efficient growth.
What Is a Trending Market? A Complete Guide to Identifying Trending Markets and Growing Profits
Successful trading depends on aligning with market conditions, especially trends. This article explains how to distinguish trending from range-bound markets, identify uptrends and downtrends, use key technical tools for entries and exits, and avoid common mistakes that lead to losses.
Judo Capital Holding (ASX: JDO) Credit Shock: Falls Hard, but the Chart Is Now Screaming “Decision Point”
Judo Capital (ASX: JDO) has dropped sharply after a credit-quality shock, lifting cost-of-risk guidance and cutting profit forecasts. Heavy selling, oversold technicals, and weak sentiment now define the stock, though long-term growth signals remain partly intact.
Ansell (ASX: ANN): Margin Expansion and Operational Resilience Through Transition
Ansell (ASX: ANN) delivers double‑digit earnings growth, disciplined cost control, and strong cash conversion amid subdued market conditions, reinforcing margin resilience and balance‑sheet strength.
Mesoblast (ASX: MSB): Shares Declined Despite Ryoncil Momentum as Investors Lock In Profits
Mesoblast (ASX: MSB) is transitioning into a commercial-stage biotech as Ryoncil® sales accelerate and its late-stage pipeline advances. While the share price has eased after a strong rally, growing revenue, improving cash flow, and multiple clinical catalysts continue to support its long-term outlook.
Artrya (ASX: AYA) Pulls Back After Testing Fresh 52-Week Highs
Artrya (ASX: AYA) is consolidating after a strong rally as investors assess its U.S. expansion, FDA progress, and commercial rollout of the AI-powered Salix platform. Despite the pullback, growing adoption and clinical milestones continue to support its long-term growth outlook.
Cyprium Metals (ASX: CYM): Re‑Emerging as Australia’s Next Copper Producer
Cyprium Metals (ASX: CYM) advances toward first copper cathode production at Nifty, backed by strong funding, disciplined execution, and a clear growth pipeline across Western Australia.
Avecho Biotechnology (ASX: AVE): Breakout Above Long-Term Resistance Puts Trend Sustainability in Focus
Avecho’s rally reflects Phase III CBD-insomnia progress, patent wins, and improving investor confidence. The biotech commercialises its TPM delivery platform across pharma, skincare, and animal health, while its production business supports higher-risk human health programs.
4DMedical (ASX: 4DX): Pulls Back After Breakout Rally
4DMedical slipped to A$4.57 after its breakout rally, as traders took profit near A$5.00. Momentum remains constructive, but holding A$4.25–A$4.50 is crucial while CT expansion, acquisitions and SaaS growth support the broader story.
Woodside Energy Group (ASX: WDS): Repricing Resilience and Capital Discipline
Woodside Energy (ASX: WDS) delivers strong cash generation, disciplined capital allocation, and resilient margins amid volatile LNG markets, positioning for long‑term value through diversified energy growth.
Auckland International Airport (ASX: AIA): Infrastructure Momentum Meets Earnings Resilience
Auckland Airport (ASX: AIA) delivers steady earnings growth, strong passenger recovery, and disciplined infrastructure execution, positioning New Zealand’s gateway for long‑term value creation.
WiseTech Global Drops Sharply as Investors Rush for the Exit
WiseTech Global shares have fallen sharply amid bearish sentiment and heavy selling pressure. The logistics software company continues to expand its CargoWise platform and invest in AI and digital trade solutions, but investors remain cautious as the stock trades near multi-month lows.
Is Breakout in Clinuvel Pharmaceuticals (ASX: CUV) Signalling a Sustainable Bullish Reversal?
CLINUVEL is a global photomedicine group commercialising SCENESSE for rare disorders while advancing vitiligo, ACTH and porphyria programs. Recent share strength reflects EMA vitiligo progress, stronger pipeline visibility and Nasdaq listing plans, though Phase III, regulatory and competition risks remain.
Lotus Resources (ASX: LOT) Surges as Selling Pressure Continues to Ease
Lotus Resources (ASX: LOT) jumped 14% to $0.66 as investors responded to improving uranium market sentiment and progress at its Kayelekera and Letlhakane projects. The company continues to ramp up production in Malawi while advancing plans to become a potential 5.5 M lb-per-year uranium producer.
Premier Investments (ASX: PMV): Defensive Strength Meets Dividend Momentum
Premier Investments (ASX: PMV) delivers resilient earnings, strong cash generation, and a reinstated dividend amid retail headwinds. Its diversified brand portfolio and disciplined capital management underpin long‑term shareholder value.
Has BrainChip Holdings (ASX: BRN) Broken Its Downtrend and Started Building a New Support Base?
BrainChip develops low-power edge AI chips via its Akida platform. Recent momentum reflects licensing and product roadmap optimism, but weak revenue, losses, and dilution remain risks. Technically, BRN has broken its downtrend and is testing support near 0.16 to 0.17.
Domino’s Pizza Enterprises (ASX: DMP): Resetting for Sustainable Growth and Margin Discipline
Domino’s Pizza Enterprises (ASX: DMP) delivers disciplined margin recovery, stronger franchisee economics, and robust cash generation amid a global reset. Execution consistency and cost control underpin sustainable growth momentum.
Capricorn Metals (ASX: CMM): A High-Margin Gold Engine Scaling for 300koz Growth
Capricorn Metals (ASX: CMM) delivers strong cash generation and mine expansion momentum, positioning for 300koz annual production through Karlawinda and Mt Gibson growth. Premium valuation reflects execution strength and long-life margins.